Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Natasha G. Bolick"'
Publikováno v:
Clinical and Translational Science, Vol 15, Iss 1, Pp 92-104 (2022)
Abstract Determining feasibility and tolerability of large volume viscous subcutaneous injection may enable optimized, intuitive delivery system design. A translational early feasibility clinical study examined large volume subcutaneous injection via
Externí odkaz:
https://doaj.org/article/fcee61b2f8114376a2ee17906441544b
Autor:
Wendy D. Woodley, Wen Yue, Didier R. Morel, Audrey Lainesse, Ronald J. Pettis, Natasha G. Bolick
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 3, Pp 859-869 (2021)
An investigational wearable injector (WI), the BD Libertas Wearable Injector (BD Libertas is a trademark of Becton, Dickinson and Company), was evaluated in an early feasibility clinical study for functional performance, tissue effects, subject toler
Externí odkaz:
https://doaj.org/article/69190dd5c1e6479392203ad0bbdf4f49
Autor:
Ronald J. Pettis, Wendy D. Woodley, Kevin C. Ossege, Adam Blum, Natasha G. Bolick, Christopher J. Rini
Publikováno v:
Drug Delivery and Translational Research.
Subcutaneous (SC) delivery is a preferred route of administration for biotherapeutics but has predominantly been limited to volumes below 3 mL. With higher volume drug formulations emerging, understanding large volume SC (LVSC) depot localization, di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::870d933ad3731feecc61fe911443be6e
https://doi.org/10.1007/s13346-023-01318-7
https://doi.org/10.1007/s13346-023-01318-7